INSIGHTS ON DRUG DEVELOPMENT

• Overcoming Challenges To High-Concentration Formulation Development

  Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.

• Shifting Drug Development With Advanced Analytical Characterization

  Explore the advancing mass spectrometry, biophysical characterization, automated sample preparation, and high throughput analytics required to deliver medicines in a safe, compliant, and efficient manner.

• Rapid Delivery Of Toxicological Study Material: Accelerating Development

  Explore key strategies and technologies designed to address the analytical considerations and material flows to facilitate the rapid delivery of toxicological material.

• One-Step SAR: Using High-Content Imaging To Drive Small Molecule Protein Degraders From Hit To Lead

  Discover Curia’s cost-effective high-content immunofluorescence workflow using the Revvity Opera Phenix™ system to efficiently identify small molecule protein degraders with rich, multi-dimensional data.

• Analytical Method Release And Stability Platform For RNA Drug Substance

  3/14/2025

  We offer comprehensive analytical support across the R&D space, including method development, validation, process characterization, in-process testing, process validation, and GMP release testing.

• Supply-Chain Statistics And Realistic Outsourcing Options

  3/12/2025

  Kishore Hotha, President, Dr. Hotha’s Life Sciences, provides some telling stats that should inform outsourcing decision-making in the coming months… and perhaps years.

• Remind Me: Why Are We At Biotech War With China?

  3/12/2025

  It’s hard to focus on the issues that precipitated the challenges and proscribed solutions to so much of our supply chain being in China. IP was (and should be) at the center of the discussion.

• Good 'Supplier Hygiene' Before And After COVID And The BIOSECURE Act

  3/12/2025

  Can you recall the fundamentals of outsourcing development and manufacturing five or 10 years ago, if you were in the industry then? Our panel can, and it’s instructive to take the trip back in time.